Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic and the weight-loss drug Wegovy — could genuinely help individuals struggling with alcohol addiction drink less and crave alcohol less frequently.

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces the risk of major cardiovascular events, such as heart a

Anne-Marie Zanzal, 60, and her wife Tonda McKay, 62, have also experienced the more positive changes that weight-loss drugs can have on romantic relationships. They say they had reached the "fat and happy stage of life" but realized being overweight was affecting their energy levels.

Ozempic and similar drugs are popular with consumers for their weight-loss properties, but a new study suggests they could have a harmful side effect that

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research. The study was small — just 48 adults — and lasted just over two months,